av/larimar-therapeutics--big.svg

NASDAQ:LRMR

Larimar Therapeutics

  • Stock

USD

Last Close

8.05

30/08 20:00

Market Cap

584.11M

Beta: 0.17

Volume Today

162.95K

Avg: 214.37K

PE Ratio

−8.34

PFCF: −12.08

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-36.48M
-
-74.29M
103.65%
-57.88M
22.09%
-52.03M
10.11%
-61.37M
17.95%
-23.13M
62.31%
-42.48M
83.65%
-50.64M
19.19%
-35.35M
30.18%
-36.95M
4.51%
depreciation and amortization
16K
-
70K
337.50%
212K
202.86%
188K
11.32%
261K
38.83%
78K
70.11%
155K
98.72%
326K
110.32%
318K
2.45%
311K
2.20%
deferred income tax
-815K
-
-8.58M
953.01%
-9.63M
-
3.63M
137.74%
-8.64M
-
stock based compensation
1.55M
-
8.58M
452.61%
9.63M
-
129K
98.66%
2.16M
1,575.19%
5.47M
153.26%
6.62M
20.94%
7.62M
15.05%
change in working capital
815K
-
6.73M
725.64%
-50.56M
851.40%
-23.37M
53.77%
10.39M
144.46%
226K
97.83%
-2.04M
1,003.98%
2.75M
234.46%
1.67M
39.24%
-2.51M
250.45%
accounts receivables
1.29M
-
inventory
-1.29M
-
accounts payables
815K
-
4.91M
502.94%
4.92M
0.18%
-448K
109.10%
-570K
27.23%
2.63M
561.40%
-3.29M
225.02%
-974K
70.38%
26K
102.67%
-403K
1,650%
other working capital
-815K
-
1.81M
322.70%
-55.48M
3,157.02%
-22.93M
58.68%
10.96M
147.82%
-2.40M
121.93%
1.25M
151.79%
3.72M
198.88%
1.64M
55.85%
-2.11M
228.30%
other non cash items
6.67M
-
7.93M
18.97%
56.25M
609.10%
31.43M
44.13%
-772K
102.46%
-3.63M
370.60%
10K
100.28%
-15K
250%
-820K
5,366.67%
6.71M
918.90%
net cash provided by operating activities
-28.24M
-
-59.55M
110.88%
-51.98M
12.73%
-43.78M
15.76%
-51.49M
17.59%
-22.70M
55.91%
-42.20M
85.91%
-42.10M
0.22%
-27.57M
34.52%
-33.46M
21.36%
investments in property plant and equipment
-58K
-
-595K
925.86%
-660K
10.92%
-55K
91.67%
-108K
96.36%
-83K
23.15%
-62K
25.30%
-333K
437.10%
-100K
69.97%
-164K
64%
acquisitions net
91.50M
-
6.76M
-
-26.03M
485.07%
-1.30M
95.02%
-24.50K
98.11%
90.86K
470.83%
purchases of investments
-57.20M
-
-287.49M
402.61%
-117.15M
-
-82.86M
29.27%
-24.49M
70.45%
-8.25M
66.32%
-133.61M
1,519.91%
-101.23M
24.23%
sales maturities of investments
195.99M
-
110.39M
-
109.47M
0.83%
1M
99.09%
32.75M
3,175%
42.75M
30.53%
134.75M
215.20%
other investing activites
-57K
-
-91.52M
160,466.67%
52.11M
156.93%
35.70M
31.48%
-6.76M
118.93%
-583K
91.37%
41.93M
7,292.80%
24.50K
99.94%
-90.86K
470.83%
net cash used for investing activites
-57.31M
-
-92.12M
60.72%
51.45M
155.85%
35.65M
30.71%
-6.87M
119.26%
-83K
98.79%
17.09M
20,690.36%
24.17M
41.42%
-90.96M
476.35%
33.35M
136.67%
debt repayment
common stock issued
3.57M
-
19.39M
-
75.59M
289.75%
19.89M
73.69%
75.26M
278.46%
30K
99.96%
common stock repurchased
131.02M
-
220K
99.83%
195K
11.36%
67.22M
34,371.79%
dividends paid
other financing activites
104.57M
-
-1.85M
101.77%
-2.94M
58.31%
16.37M
657.65%
-312K
101.91%
19.39M
6,316.35%
18.00M
7.22%
net cash used provided by financing activities
108.14M
-
129.16M
19.44%
-2.71M
102.10%
16.56M
710.02%
66.91M
303.99%
19.39M
71.01%
93.59M
382.53%
19.89M
78.75%
75.26M
278.46%
30K
99.96%
effect of forex changes on cash
-58.10M
-
net change in cash
22.59M
-
-80.61M
456.91%
-3.24M
95.98%
8.43M
359.79%
8.55M
1.53%
-3.39M
139.60%
68.48M
2,121.79%
1.95M
97.15%
-43.27M
2,320.22%
-76K
99.82%
cash at beginning of period
35.52M
-
58.10M
63.59%
35.59M
38.74%
32.35M
9.11%
40.78M
26.04%
4.40M
89.22%
1.01M
77.05%
69.49M
6,786.72%
71.44M
2.80%
26.82M
62.45%
cash at end of period
58.10M
-
-22.51M
138.74%
32.35M
243.74%
40.78M
26.04%
49.33M
20.98%
1.01M
97.95%
69.49M
6,786.72%
71.44M
2.80%
28.16M
60.57%
26.75M
5.02%
operating cash flow
-28.24M
-
-59.55M
110.88%
-51.98M
12.73%
-43.78M
15.76%
-51.49M
17.59%
-22.70M
55.91%
-42.20M
85.91%
-42.10M
0.22%
-27.57M
34.52%
-33.46M
21.36%
capital expenditure
-58K
-
-595K
925.86%
-660K
10.92%
-55K
91.67%
-108K
96.36%
-83K
23.15%
-62K
25.30%
-333K
437.10%
-100K
69.97%
-164K
64%
free cash flow
-28.30M
-
-60.15M
112.55%
-52.63M
12.49%
-43.84M
16.71%
-51.59M
17.69%
-22.78M
55.84%
-42.26M
85.50%
-42.44M
0.42%
-27.67M
34.80%
-33.62M
21.52%

All numbers in USD (except ratios and percentages)